(Q34775377)

4 August 2017

title

Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma (English)

1 reference

4 August 2017

0 references

8

Bernard Meunier

1 reference

4 August 2017

Laurent Sulpice

1

1 reference

4 August 2017

Michel Rayar

2

1 reference

4 August 2017

Mireille Desille

3

1 reference

4 August 2017

Bruno Turlin

4

1 reference

4 August 2017

Alain Fautrel

5

1 reference

4 August 2017

Eveline Boucher

6

1 reference

4 August 2017

Francisco Llamas-Gutierrez

7

1 reference

4 August 2017

Karim Boudjema

9

1 reference

4 August 2017

Bruno Clément

10

1 reference

4 August 2017

Cédric Coulouarn

11

1 reference

4 August 2017

language of work or name

English

0 references

publication date

17 October 2013

1 reference

4 August 2017

1 reference

4 August 2017

volume

58

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

1992-2000

1 reference

4 August 2017

cites work

Global cancer statistics

1 reference

Cholangiocarcinomas can originate from hepatocytes in mice

21 January 2018

1 reference

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

21 January 2018

1 reference

Biliary tract cancers in Olmsted County, Minnesota, 1976-2008.

21 January 2018

1 reference

Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk

21 January 2018

1 reference

Survival analysis of intrahepatic cholangiocarcinoma after resection.

21 January 2018

1 reference

Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma

21 January 2018

1 reference

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma

21 January 2018

1 reference

21 January 2018

Fibroblasts in cancer

1 reference

Tumor stroma derived biomarkers in cancer

21 January 2018

1 reference

Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma

21 January 2018

1 reference

The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma

21 January 2018

1 reference

Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin.

21 January 2018

1 reference

Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis.

21 January 2018

1 reference

Next generation software for functional trend analysis

21 January 2018

1 reference

Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways

21 January 2018

1 reference

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

21 January 2018

1 reference

Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer

21 January 2018

1 reference

ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments

21 January 2018

1 reference

Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation

21 January 2018

1 reference

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors

21 January 2018

1 reference

Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma

21 January 2018

1 reference

Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma

21 January 2018

1 reference

Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes

21 January 2018

1 reference

Stromal gene expression predicts clinical outcome in breast cancer

21 January 2018

1 reference

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

Stromal LRP1 in lung adenocarcinoma predicts clinical outcome

21 January 2018

1 reference

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

21 January 2018

1 reference

Overexpression of osteopontin in hepatocellular carcinoma

21 January 2018

1 reference

Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling

21 January 2018

1 reference

Osteopontin regulates epithelial mesenchymal transition-associated growth of hepatocellular cancer in a mouse xenograft model

21 January 2018

1 reference

Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.

21 January 2018

1 reference

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma

21 January 2018

1 reference

Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.

21 January 2018

1 reference

Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers

21 January 2018

1 reference

Identification of osteopontin as a novel marker for early hepatocellular carcinoma

21 January 2018

1 reference

Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis.

21 January 2018

1 reference

Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma

21 January 2018

1 reference

Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysis

21 January 2018

1 reference

The role of liver transplantation for intrahepatic cholangiocarcinoma: a single-center experience

21 January 2018

1 reference

Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma

21 January 2018

1 reference

Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer

21 January 2018

1 reference

Treatment of recurrent intrahepatic cholangiocarcinoma

21 January 2018

1 reference

7 January 2021

Irinotecan with 5-FU/FA in advanced biliary tract adenocarcinomas: a multicenter phase II trial

1 reference

7 January 2021

Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas

1 reference

7 January 2021

Tumor stroma reaction-related gene signature predicts clinical outcome in human hepatocellular carcinoma

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26577

1 reference

4 August 2017

1 reference